Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urogenital aging--a hidden problem

G Samsioe1

  • 1Department of Obstetrics and Gynecology, University of Lund, University Hospital, Sweden.

American Journal of Obstetrics and Gynecology
|June 3, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmö Diet and Cancer Study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.

Climacteric : the journal of the International Menopause Society·2009
Same author

Sociodemographic risk factors of metabolic syndrome in middle-aged women: results from a population-based study of Swedish women, The Women's Health in the Lund Area (WHILA) Study.

Climacteric : the journal of the International Menopause Society·2008
Same author

Symptoms in peri- and postmenopausal women in relation to testosterone concentrations: data from The Women's Health in the Lund Area (WHILA) study.

Climacteric : the journal of the International Menopause Society·2008
Same author

Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: The Women's Health in the Lund Area (WHILA) Study.

Climacteric : the journal of the International Menopause Society·2007
Same author

Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2007
Same journal

Likelihood ratios enhance clinical interpretation of metagenomic prediction of early-onset neonatal sepsis in preterm premature rupture of membranes (Letter-to-the-Editor).

American journal of obstetrics and gynecology·2026
Same journal

Taking risk stratification in preterm premature rupture of membranes to the bedside (Reply to Letter-to-the-Editor).

American journal of obstetrics and gynecology·2026
Same journal

Gestational Age at Full-Term Delivery and Long-Term Offspring Morbidity in Low-Risk Pregnancies: A Population-Based Cohort Study.

American journal of obstetrics and gynecology·2026
Same journal

Trajectories of childbirth-related posttraumatic stress symptoms after a vaginal delivery: a multicenter prospective study.

American journal of obstetrics and gynecology·2026
Same journal

Early life adversity and polycystic ovary syndrome among North American pregnancy planners.

American journal of obstetrics and gynecology·2026
Same journal

Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer.

American journal of obstetrics and gynecology·2026
See all related articles

Low-dose estrogen therapy can effectively treat urogenital and vaginal symptoms in postmenopausal women. This approach avoids endometrial proliferation, allowing treatment without progestogen, addressing common aging-related issues.

Area of Science:

  • Gerontology
  • Gynecology
  • Urology

Background:

  • Urogenital problems affect one-third of women over 50.
  • Symptoms include incontinence, urethritis, UTIs, vaginal dryness, and dyspareunia.
  • Estrogen deficiency contributes to these age-related changes.

Purpose of the Study:

  • To evaluate the efficacy of low-dose estrogen therapy for urogenital atrophy.
  • To determine if estrogen can be used without progestogen due to low endometrial risk.
  • To understand the impact of estrogen on vaginal microflora and pH.

Main Methods:

  • Administration of low-dose estrogen preparations.
  • Monitoring of urogenital and vaginal symptoms.
  • Assessment of endometrial proliferation and systemic absorption.

Related Experiment Videos

  • Analysis of vaginal microflora and pH changes.

    • Main Results:

    • Low-dose estrogen effectively corrects atrophic changes in the bladder neck and urethra.
    • Estrogen therapy improves vaginal dryness, dyspareunia, and recurrent vaginitis.
    • Vaginal pH normalizes, and lactobacilli-dominant microflora is restored.
    • Systemic absorption of estrogen is dependent on vaginal mucosa status.

    Conclusions:

    • Low-dose estrogen is a safe and effective treatment for menopausal urogenital atrophy.
    • Treatment can be administered without progestogen, minimizing risks.
    • Estrogen therapy improves quality of life for aging women by addressing urogenital health.